ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics-Reference-Cited by-同舟云学术

ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics

Published:2014-02-24 Issue:3-4 Volume:15 Page:192-203
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Mitsumoto Hiroshi,Factor-Litvak Pam,Andrews Howard,Goetz Raymond R.,Andrews Leslie,Rabkin Judith G.,McElhiney Martin,Nieves Jeri,Santella Regina M.,Murphy Jennifer,Hupf Jonathan,Singleton Jess,Merle David,Kilty Mary,Heitzman Daragh,Bedlack Richard S.,Miller Robert G.,Katz Jonathan S.,Forshew Dallas,Barohn Richard J.,Sorenson Eric J.,Oskarsson Bjorn,Fernandes Filho J. Americo M.,Kasarskis Edward J.,Lomen-Hoerth Catherine,Mozaffar Tahseen,Rollins Yvonne D.,Nations Sharon P.,Swenson Andrea J.,Shefner Jeremy M.,Andrews Jinsy A.,Koczon-Jaremko Boguslawa A.,

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology

Link

http://www.tandfonline.com/doi/pdf/10.3109/21678421.2013.864312

Reference79 articles.

1. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis

2. Oxidative stress in neurodegeneration: cause or consequence?

3. Molecular and cellular pathways of neurodegeneration in motor neurone disease

4. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: Mechanisms of mitochondriopathy and cell death

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis;Annals of Neurology;2023-11-29

2. Rare variant analyses validate known ALS genes in a multi-ethnic population and identifiesANTXR2as a candidate in PLS;2023-10-02

3. CNM-Au8: an experimental agent for the treatment of amyotrophic lateral sclerosis (ALS);Expert Opinion on Investigational Drugs;2023-08-03

4. Analysis of the spatial distribution of amyotrophic lateral sclerosis in Virginia;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2023-07-14

5. Utilizing machine learning and lipidomics to distinguish primary lateral sclerosis from amyotrophic lateral sclerosis;Muscle & Nerve;2023-02-20